Home > Insider Trading > Filing (0001179110-16-031609)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1005201	Depomed Inc	DEPO	Pharmaceutical Preparations (2834)	943229046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1344412	J August Moretti	C/O Depomed Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560	Chief Financial Officer & Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-14	5,000	$12.69	26,680	No	4	M	Direct
Common Stock	Disposition	2016-11-14	5,000	$20.84	21,680	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2016-11-14	5,000	$0.00	5,000	$12.69

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
48,741		2024-02-18	No	4	M	Direct

Footnotes

Represents shares sold pursuant to a 10b5-1 plan adopted on March 12, 2015.
Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
57,038 stock options were granted on February 18, 2014 and were exercisable in 48 equal monthly installments.